Abstract
The aim of the present study was to analyse the survival rate in a group of breast cancers detected in the intervals between screening examinations in relation to clinically detected cancers in a non-screened population. All interval and control cancers were recruited from a randomized controlled mammography screening trial in Stockholm. The overall survival up to eight years of observation was higher in 191 patients with interval cancers than in 142 control cancers (p=0.01). There were no significant differences between the two groups with regard to tumor size, stage distribution, or mean age, though the interval group did have a larger proportion of younger women. The similarity was confirmed by multiple regression analysis. The overall survival stage by stage was consistently higher in interval cancers. The survival rate in the true interval cancers was similar to that for those found in retrospect to have been detectable or traceable at the time of screening. No correlation was found between the length of the interval and the survival of patients with interval cancers. These results contradict the hypothesis that a high growth rate is associated with a poorer prognosis and that interval cancers are a more aggressive form of breast neoplasia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
De Groote R, Rush BF, Milazzo J, Warden MJ, Rocho JM: Interval breast cancer: A more aggressive subset of breast neoplasias. Surgery 94: 543–547, 1983
Heuser LS, Spratt JS, Kuhns JG, Chang AFC, Polk HC Jr, Buchanan JB: The association of pathologic and mammographic characteristics of primary human breast cancers with ‘slow’ and ‘fast’ growth rates and with axillary lymph node metastases. Cancer 53: 96–98, 1984
Fournier D, Weber E, Hoeffner W, Kubbi F, Barth V: Growth rate of 147 mammary carcinomas. Cancer 45: 2198–2207, 1980
Heuser L, Spratt JS, Polk HO Jr, Buchanan J: Relation between mammary cancer growth kinetics and the intervals between screenings. Cancer 43: 857–862, 1979
von Rosen A, Erhardt K, Hellström L, Somell A, Auer G: Assessment of malignancy potential in so-called interval mammary carcinomas. Breast Cancer Res Treat 6: 221–227, 1985
Frisell J, Eklund G, Hellström L, Somell A: Analysis of interval carcinomas in a randomized screening trial in Stockholm. Breast Cancer Res Treat 3: 219–225, 1987
Tabár L, Fagerberg G, Day NE, Holmberg L: What is the optimum interval between mammographic screening examinations? — An analysis on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer 55: 547–551, 1987
Holmberg L, Tabár L, Adami HO, Bergström R: Survival in breast cancer diagnosed between mammographic screening examinations. Lancet ii: 27–30, 1986
Shapiro S, Venet W, Strax P, Venet L, Roeser R: Ten to fourteen year effect of screening on breast cancer mortality. JNCI 69: 349–355, 1982
Andersson J, Aspegren K, Janzon L, Landberg T, Lindholm K, Linell F, Ljungberg O, Ranstam J, Sigfússon B: Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. Br Med J 297: 943–948, 1988
Frisell J, Glas U, Hellström L, Somell A: Randomized mammographic screening for breast cancer in Stockholm. Design, first round results, and comparisons. Breast Cancer Res Treat 8: 45–54, 1986
Lundgren B, Jakobsson S: Single view mammography: a simple and efficient approach to breast cancer screening. Cancer 38: 1124–1129, 1976
Frisell J, Eklund G, Hellström L, Glas U, Somell A: The Stockholm breast cancer screening trial — 5 year results and stage at discovery. Breast Cancer Res Treat 13: 79–87, 1989
Frisell J, Eklund G, Hellström L, Lidbrink E, Rutqvist L-E, Somell A: Randomized study of mammography screening — preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 18: 49–56, 1991
Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II: Analysis and examples. Br J Cancer 35: 1–39, 1977
Cox DR: Regression models and life-tables (with discussion). J Royal Statist Soc B 34: 187–220, 1972
Tabár L, Fagerberg G, Gad A, Baldetorp L, Holmberg LH, Gröntoft D, Ljungqvist U, Lundström B, Månsson IC, Eklund G, Pettersson F, Day NE: Reduction in mortality from breast cancer after mass screening with mammography. Lancet i: 829–832, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Frisell, J., von Rosen, A., Wiege, M. et al. Interval cancer and survival in a randomized breast cancer screening trial in Stockholm. Breast Cancer Res Tr 24, 11–16 (1992). https://doi.org/10.1007/BF01832353
Issue Date:
DOI: https://doi.org/10.1007/BF01832353